ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.81+0.11 (+2.34%)

Delayed quote: Oct 6, 2026, 10:56 AM EDT

ImageneBio (IMA) Price/FCF Ratio: History & Chart | TGMCharts

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T15:07:08.082Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:07:08.082Z.

Quote observation: 2026-10-06T14:56:10.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 54,252,471
TTM free cash flow · period ending 2026-06-30: -57,733,000

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IMA Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

IMA Competitors' Price/FCF Ratio

IMA

ImageneBio Inc

Current

Market Cap

$54.25M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.33M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$55.53M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs IMA

Market Cap

$52.13M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$54.89M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs IMA

Market Cap

$52.46M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKYO

OKYO Pharma Limited

vs IMA

Market Cap

$56.78M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs IMA

Market Cap

$52.05M

Price/FCF Ratio

2.64

TTM Avg

2.45

3Y Avg

5.29

5Y Avg

4.64

COCH

Envoy Medical, Inc.

vs IMA

Market Cap

$51.33M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLD

Boundless Bio, Inc.

vs IMA

Market Cap

$57.98M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
ImageneBio Inc (IMA)	$54.25M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.33M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$55.53M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.13M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$54.89M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
OKYO Pharma Limited (OKYO)vs ›	$56.78M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$52.05M	2.64	2.45	5.29	4.64
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	N/A	N/A	N/A
Boundless Bio, Inc. (BOLD)vs ›	$57.98M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

IMA Price/FCF Ratio Metrics

IMA Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics